Tonix recently reported results from second positive Phase 3 trial of Tonmya™ for the management of fibromyalgia In the U.S., New Drug Application (NDA) submission to the FDA planned for the second half of 2024 In Japan, China and most countries in Europe cyclobenzaprine is a New Chemical Entity CHATHAM, N.J., March 12, 2024 (GLOBE NEWSWIRE) Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of developme
Fibromyalga is a contested diagnosis and many health professionals believe it does not exist as a true disease, and that it is in the patient's minds, making it psychological or psycho-somatic in nature, said Saumya Pahwa, a consultant clinical psychologist
What causes fibromyalgia remains largely unknown, making its treatment difficult. A new study reveals the neural mechanisms behind this chronic pain disorder. TheHealthSite.com